分权化耐药结核病治疗启动服务
N Murphy-Okpala1, C Eze1, I N Orabueze2
1Department of Programs, RedAid Nigeria, Enugu, Nigeria.
IJTLD open
|December 15, 2025
概括
尼日利亚去中心化耐药结核病 (DR-TB) 服务显著改善了治疗入学率,并减少了延迟. 这项研究表明,将DR-TB护理更接近患者,可以改善治疗的准入和及时启动.
科学领域:
- 公共卫生 公共卫生
- 传染病管理 传染病管理
- 医疗保健系统研究 医疗保健系统研究
背景情况:
- 尼日利亚的集中式耐药结核病 (DR-TB) 护理导致了大量的治疗前损失至随访 (PTLTFU) 和延迟开始治疗.
- 有效协调DR-TB服务对于改善患者的治疗结果和减少治疗流失至关重要.
研究的目的:
- 评估DR-TB服务的去中心化对尼日利亚南部治疗入学和治疗时间启动的影响.
- 评估多方面的干预措施的有效性,旨在通过分散来改善DR-TB护理协调.
主要方法:
- 在尼日利亚南部,在15个月的时间里,采用了一种准实验性研究设计.
- 在干预国家实施了包括八个组成部分的多层次干预.
- 数据通过桌面审查形式收集并分析,以比较干预和控制状态之间的结果.
主要成果:
- 分权化显著增加了干预状态的DR-TB患者的治疗入学率 (79.1%),而不是对照状态 (66.0%).
- 在干预状态下,治疗前损失到随访 (PTLTFU) 显著下降 (从39.5%降至20.9%),但在对照状态下增加.
- 在干预状态 (17至14天) 和对照状态 (21至15天) 中,治疗开始的中位时间在干预后减少,干预状态的减少更为明显.
结论:
- 分散DR-TB服务是减少诊断-入学差距和加快治疗启动的有效策略.
- 这些发现支持在尼日利亚的医疗保健系统中扩展分散的DR-TB护理模式.
相关概念视频
01:28Pulmonary Tuberculosis V
523
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
523
01:26Pulmonary Tuberculosis IV
468
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
468
01:29Pulmonary Tuberculosis I
802
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
802
01:28Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
01:31Pulmonary Tuberculosis III
890
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
890
01:29Therapeutic Drug Monitoring: Affecting Factors
175
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
175